Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

23andMe Holding Co. - Common Stock (NQ: ME )

3.440 -0.200 (-5.49%)
Streaming Delayed Price Updated: 2:50 PM EST, Jan 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about 23andMe Holding Co. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's morning session, 216 companies made new 52-week lows. Noteworthy Points: Alibaba Group Holding (NYSE:BABA) was the largest firm by market cap... 
Via Benzinga
The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 26) Absci, CORP (NASDAQ: ABSI... 
Via Benzinga
The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 22) Bio-Techne Corporation (... 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's morning session saw 27 companies set new 52-week lows. Points of Interest: The company with the largest market cap to set a new 52-week low was... 
Via Benzinga
Cramer Weighs In On Baidu, Clorox And More
On CNBC's "CNBC's "Mad Money Lightning Round," Jim Cramer said he's not going to fight Reinvent Technology Partners (NYSE: RTP) because this SPAC is... 
Via Benzinga
Is 23andMe a Buy at $11?
Yes, but it'll take a while to grow with gusto. 
Via The Motley Fool
2 Growth Stocks to Put on Your Radar
Here are two stocks our experts are keeping their eye on right now. 
Via The Motley Fool
Can You Count on 23andMe Stock?
This innovative consumer genetic testing company is more than meets the eye. 
Via The Motley Fool
ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut
23andMe (ME) stock is on the move Friday after the genetics company made its public debut on the Nasdaq Exchange yesterday. 
Via InvestorPlace
50 Biggest Movers From Yesterday
Gainers Verve Therapeutics, Inc. (NASDAQ: VERV) shares surged 68% to settle at $31.92 on Thursday after the company priced its IPO at $19 per share. Midatech Pharma plc (NASDAQ... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.